Evidence map›Paper›PMID 42866273›Full record

ArticleJAMIA open2026

Avoiding "shiny objects" and heeding "red flags": a sensemaking framework for emerging technology procurement.

Wiljeana Glover, Dessislava Pachamanova, Derick R Simmons, Robin Sodano, Eric Alper

Abstract readCase Reports
In one paragraph

Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wiljeana GloverKletjian Foundation Distinguished Professor of Health Innovation and Entrepreneurship, Operations and Information Management Division, Babson College, Wellesley, MA 02457, United States.ORCID https://orcid.org/0000-0002-7754-2575
Dessislava PachamanovaZwerling Family Endowed Term Chair, Mathematics, Analytics, Science and Technology Division, Babson College, Wellesley, MA 02457, United States.ORCID https://orcid.org/0000-0002-1373-1553
Derick R SimmonsDoctoral Candidate, Saint Louis University, St. Louis, Missouri 63103, United States.
Robin SodanoSenior Vice President, Information Services, UMass Memorial Health, Worcester, MA 01605, United States.
Eric AlperChief Quality Officer, Chief Clinical Informatics Officer, UMass Memorial Health, Worcester, MA 01605, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Health systems can be vulnerable to "shiny object syndrome," adopting unneeded emerging technologies (ETs), or may ignore "red flags" if they rely on linear health technology procurement processes that exclude the influence of information exchanges between the health system, vendors, and industry partners. Methods: We conduct a post-hoc comparison of 2 procured communication-related clinical workflow ETs and examine ET-related IT Committee meetings within an academic medical center. We apply sensemaking theory, highlighting examples where sense-giving, sense-demanding, and sense-breaking were present or absent across stakeholders during procurement. Results: Present (or absent) sensemaking dynamics demonstrated reciprocity (or lack thereof) across all 3 sensemaking components. Sense-breaking particularly informed committee meetings, leading to new technological and organizational infrastructure. Conclusions: Our emergent sensemaking ET procurement framework offers 3 actionable recommendations: formalize multi-stakeholder information exchange roles, treat vendor responsiveness to sense-demanding as a selection criterion, and use each procurement cycle to surface and address foundational governance and infrastructure gaps.

Indexed as

emerging technologiessensemakingtechnology procurement

Identifiers

PMID42866273
PMCPMC13657256

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.